The global Ophthalmoplegia Market is expected to grow at a CAGR of 7.12% from 2017 to 2025.
Ophthalmoplegia is the paralysis or weakness of the eye muscles. It can affect one or more of the six muscles that hold the eye in place and control its movement. Rising geriatric population and increasing healthcare awareness and concerns are some of the factors driving the market.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Increasing geriatric population
1.2 Rising number of diseases including strokes, thyroid disease, brain tumor
1.3 Increasing prevalence of eye sight affecting diseases
2. Market Restraints
2.1 High Cost of Treatment
Market Segmentation:
1. Global Ophthalmoplegia Market, by Type:
1.1 external Ophthalmoplegia
1.2 internuclear Ophthalmoplegia
2. Global Ophthalmoplegia Market, by Treatment:
2.1 surgery
2.2 drug treatment
3. Global Ophthalmoplegia Market, by End User:
3.1 hospitals
3.2 clinics
3.3 ambulatory centers
4. Global Ophthalmoplegia Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Abbott
2. Novartis AG
3. ZEISS International
4. Valeant, Amritt, Inc.
5. Medline Industries, Inc.
6. ALLERGAN
7. Johnson & Johnson Private Limited
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Ophthalmoplegia Market was performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL OPHTHALMOPLEGIA MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL OPHTHALMOPLEGIA MARKET OUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL OPHTHALMOPLEGIA MARKET, BY TYPE
5.1 External Ophthalmoplegia
5.2 Internuclear Ophthalmoplegia
6 GLOBAL OPHTHALMOPLEGIA MARKET, BY TREATMENT
6.1 Surgery
6.2 Drug treatment
7 GLOBAL OPHTHALMOPLEGIA MARKET, BY END USER
7.1 Hospitals
7.2 Clinics
7.3 Ambulatory centers
8 GLOBAL OPHTHALMOPLEGIA MARKET, BY GEOGRAPHY
8.1 Overview
8.2 North America Regional Market Estimates and Forecasts, 2012 - 2025
8.2.1 U.S.
8.2.2 Canada
8.2.3 Mexico
8.3 Europe Regional Market Estimates and Forecasts, 2012 - 2025
8.3.1 Germany
8.3.2 U.K.
8.3.3 France
8.3.4 Rest of Europe
8.4 Asia Pacific Regional Market Estimates and Forecasts, 2012 - 2025
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Rest of Asia Pacific
8.5 Latin America Regional Market Estimates and Forecasts, 2012 - 2025
8.5.1 Brazil
8.5.2 Argentina
8.6 Rest of the World Regional Market Estimates and Forecasts, 2012 â€" 2025
9 GLOBAL OPHTHALMOPLEGIA MARKET COMPETITIVE LANDSCAPE
9.1 Overview
9.2 Company Market Share
9.3 Vendor Landscape
9.4 Key Development Strategies
10 COMPANY PROFILES
10.1 Abbott
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2 Novartis AG
10.2.1 Overview
10.2.2 Financial Performance
10.2.3 Product Outlook
10.2.4 Key Developments
10.3 ZEISS International
10.3.1 Overview
10.3.2 Financial Performance
10.3.3 Product Outlook
10.3.4 Key Developments
10.4 Valeant, Amritt, Inc.
10.4.1 Overview
10.4.2 Financial Performance
10.4.3 Product Outlook
10.4.4 Key Developments
10.5 Medline Industries, Inc.
10.5.1 Overview
10.5.2 Financial Performance
10.5.3 Product Outlook
10.5.4 Key Developments
10.6 ALLERGAN
10.6.1 Overview
10.6.2 Financial Performance
10.6.3 Product Outlook
10.6.4 Key Developments
10.7 Johnson & Johnson Private Limited
10.7.1 Overview
10.7.2 Financial Performance
10.7.3 Product Outlook
10.7.4 Key Developments
11 Appendix
11.1 Related Reports
The global Ophthalmoplegia market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fiel...
The research team projects that the Ophthalmoplegia market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.
The prime objective of this report is to help the user u...
The global Ophthalmoplegia Market is expected to grow at a CAGR of 7.12% from 2017 to 2025.
Ophthalmoplegia is the paralysis or weakness of the eye muscles. It can affect one or more of the six muscles that hold the eye in place and control its movement. Rising geriatric population and...